54
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Visual acuity loss associated with excessive “dry macula” in exudative age-related macular degeneration

, , , , , , , & show all
Pages 369-375 | Published online: 20 Feb 2018

References

  • WongWLSuXLiXGlobal prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysisLancet Glob Health201422e106e11625104651
  • Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research GroupMartinDFMaguireMGFineSLRanibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year resultsOphthalmology201211971388139822555112
  • RosenfeldPJBrownDMHeierJSMARINA Study GroupRanibizumab for neovascular age-related macular degenerationN Engl J Med2006355141419143117021318
  • BrownDMKaiserPKMichelsMANCHOR Study GroupRanibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med2006355141432144417021319
  • ChakravarthyUHardingSPRogersCAIVAN study investigatorsAlternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trialLancet201338299001258126723870813
  • BlaauwgeersHGHoltkampGMRuttenHPolarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relationAm J Pathol1999155242142810433935
  • MarnerosAGFanJYokoyamaYVascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual functionAm J Pathol200516751451145916251428
  • Wangsa-WirawanNDLinsenmeierRARetinal oxygen: fundamental and clinical aspectsArch Ophthalmol2003121454755712695252
  • GrunwaldJEDanielEHuangJCATT Research GroupRisk of geographic atrophy in the comparison of age-related macular degeneration treatments trialsOphthalmology2014121115016124084496
  • JaffeGJMartinDFTothCAComparison of Age-related Macular Degeneration Treatments Trials Research GroupMacular morphology and visual acuity in the comparison of age-related macular degeneration treatments trialsOphthalmology201312091860187023642377
  • Diabetic Retinopathy Clinical Research NetworkBrowningDJGlassmanARAielloLPRelationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edemaOphthalmology2007114352553617123615
  • EbneterAWolfSAbhishekJZinkernagelMSRetinal layer response to ranibizumab during treatment of diabetic macular edema: thinner is not always betterRetina20163671314132326735563
  • ArnoldJJMarkeyCMKurstjensNPGuymerRHThe role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration – a phase IV randomised clinical trial with ranibizumab: the FLUID studyBMC Ophthalmol2016163127009515
  • CATT Research GroupMartinDFMaguireMGYingGSGrunwaldJEFineSLJaffeGJRanibizumab and bevacizumab for neovascular age-related macular degenerationN Engl J Med2011364201897190821526923
  • BhavsarKVFreundKBRetention of good visual acuity in eyes with neovascular age-related macular degeneration and chronic refractory subfoveal subretinal fluidSaudi J Ophthalmol201428212913324843306
  • GianniouCDiraniAJangLMantelIRefractory intraretinal or subretinal fluid in neovascular age-related macular degeneration treated with intravitreal ranizubimab: functional and structural outcomeRetina20153561195120125650710
  • WickremasingheSSJanakanVSandhuSSAmirul-IslamFMAbediFGuymerRHImplication of recurrent or retained fluid on optical coherence tomography for visual acuity during active treatment of neovascular age-related macular degeneration with a treat and extend protocolRetina20163671331133926655608
  • YamazakiTKoizumiHYamagishiTKinoshitaSSubfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month resultsOphthalmology201211981621162722551738
  • KoizumiHKanoMYamamotoAShort-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degenerationAm J Ophthalmol2015159462763325555799
  • CiullaTAHarrisAMartinBJOcular perfusion and age-related macular degenerationActa Ophthalmol Scand200179210811511284745